The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of gender on efficacy and acute toxicity in standard risk localized (SR) Ewing sarcomas (ES) in the Euro-Ewing99-R1 trial.
Hendrik Van Den Berg
No relevant relationships to disclose
Michael Paulussen
No relevant relationships to disclose
Nathalie Gaspar
No relevant relationships to disclose
Ian Lewis
No relevant relationships to disclose
Uta Dirksen
No relevant relationships to disclose
Bernadette Brennan
No relevant relationships to disclose
Gwenael Le Teuff
No relevant relationships to disclose
Jeremy Whelan
No relevant relationships to disclose
Andreas Ranft
No relevant relationships to disclose
Jean Marie Michon
No relevant relationships to disclose
Ruth Lydia Ladenstein
No relevant relationships to disclose
Perrine Marec-Berard
No relevant relationships to disclose
Lars Hjort
No relevant relationships to disclose
Keith Wheatley
No relevant relationships to disclose
Ian Robert Judson
No relevant relationships to disclose
Odile Oberlin
No relevant relationships to disclose
A. W Craft
No relevant relationships to disclose
Herbert Juergens
No relevant relationships to disclose
Marie-Cécile Le Deley
No relevant relationships to disclose